Emily Schonfeld

710 total citations
17 papers, 489 citations indexed

About

Emily Schonfeld is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Emily Schonfeld has authored 17 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Hepatology and 4 papers in Infectious Diseases. Recurrent topics in Emily Schonfeld's work include Liver Disease Diagnosis and Treatment (5 papers), Hepatitis C virus research (3 papers) and HIV/AIDS drug development and treatment (3 papers). Emily Schonfeld is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Hepatitis C virus research (3 papers) and HIV/AIDS drug development and treatment (3 papers). Emily Schonfeld collaborates with scholars based in United States, United Kingdom and Canada. Emily Schonfeld's co-authors include Maureen F. Zakowski, William Pao, Harold Varmus, Pang‐Dian Fan, Katerina Politi, Michael A. Poles, Robert S. Brown, Andrea D. Branch, Michael D. Linderman and Irvin Sam Schonfeld and has published in prestigious journals such as Genes & Development, Hepatology and Journal of Hepatology.

In The Last Decade

Emily Schonfeld

15 papers receiving 479 citations

Peers

Emily Schonfeld

ONCOL

PRM

EPIDE

Umberto Conte United States

Zhibin Cheng China

Veronica Lonati Italy

Geena X. Wu United States

Li-Chen Yen Taiwan

Raju V. Pusapati United States

Rodica Maricela Anghel Romania

Miguel Ángel Suárez Muñóz Spain

David Farrugia United Kingdom

M. Abad Spain

Umberto Conte United States

Emily Schonfeld

150 ×0.6

ONCOL

154 ×0.7

PRM

106 ×0.6

46 ×0.5

58 ×0.8

EPIDE

Citations per year, relative to Emily Schonfeld Emily Schonfeld (= 1×) peers Umberto Conte

Countries citing papers authored by Emily Schonfeld

Since Specialization

Citations

This map shows the geographic impact of Emily Schonfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Schonfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Schonfeld more than expected).

Fields of papers citing papers by Emily Schonfeld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Schonfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Schonfeld. The network helps show where Emily Schonfeld may publish in the future.

Co-authorship network of co-authors of Emily Schonfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Schonfeld. A scholar is included among the top collaborators of Emily Schonfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Schonfeld. Emily Schonfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Schonfeld, Emily, Andrea S. Kierans, Rena K. Fox, & Danielle Brandman. (2025). Using Incidental Radiologic Findings of Hepatic Steatosis to Improve the Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease. Journal of the American College of Radiology. 22(3). 358–365. 2 indexed citations

Prince, A. K., Hanna Rennert, Danielle Brandman, et al.. (2025). Common bile duct dilatation on MRI in autosomal dominant polycystic kidney disease. Abdominal Radiology. 51(2). 758–767.

Bichoupan, Kian, et al.. (2024). A Prospective Open-Label Dose–Response Study to Correct Vitamin D Deficiency in Cirrhosis. Digestive Diseases and Sciences. 69(3). 1015–1024.

Malkani, Kabir, et al.. (2023). Noncirrhotic portal hypertension in primary biliary cholangitis with coexisting CREST syndrome. Clinics and Research in Hepatology and Gastroenterology. 47(5). 102114–102114. 1 indexed citations

Izzy, Manhal, Brett E. Fortune, Marina Serper, et al.. (2022). Management of cardiac diseases in liver transplant recipients: Comprehensive review and multidisciplinary practice-based recommendations. American Journal of Transplantation. 22(12). 2740–2758. 21 indexed citations

Bianchi, Renzo, et al.. (2022). Occupational Depression in a Spanish-Speaking Sample: Associations with Cognitive Performance and Work-Life Characteristics. Journal of Work and Organizational Psychology. 38(1). 59–74. 10 indexed citations

Schonfeld, Emily & Robert S. Brown. (2019). Genetic Causes of Liver Disease. Medical Clinics of North America. 103(6). 991–1003. 10 indexed citations

Schonfeld, Emily & Robert S. Brown. (2017). Genetic Testing in Liver Disease. Clinics in Liver Disease. 21(4). 673–686. 6 indexed citations

Bichoupan, Kian, Neeta Tandon, Valérie Martel‐Laferrière, et al.. (2017). Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection. World Journal of Hepatology. 9(11). 551–551. 1 indexed citations

10.

Schwartz, Robert E., Robert S. Brown, Nicole T. Shen, et al.. (2017). Hepatology Highlights. Hepatology. 66(3). 683–685. 1 indexed citations

11.

Schonfeld, Emily, et al.. (2016). The Impact of Bariatric Surgery on Liver Disease: A Systematic Review and Meta-Analysis. The American Journal of Gastroenterology. 111. S350–S350. 1 indexed citations

12.

Schonfeld, Emily, et al.. (2015). Human Immunodeficiency Virus-Associated Diarrhea: Still an Issue in the Era of Antiretroviral Therapy. Digestive Diseases and Sciences. 60(8). 2236–2245. 42 indexed citations

13.

Bichoupan, Kian, Valérie Martel‐Laferrière, David Sachs, et al.. (2014). Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response. Hepatology. 60(4). 1187–1195. 30 indexed citations

14.

Bichoupan, Kian, Valérie Martel‐Laferrière, Emily Schonfeld, et al.. (2013). 795 REAL WORLD COSTS OF TELAPREVIR-BASED TRIPLE THERAPY, INCLUDING COSTS OF MANAGING ADVERSE EVENTS, AT THE MOUNT SINAI MEDICAL CENTER, NY: $147,000 PER EOT. Journal of Hepatology. 58. S324–S325. 6 indexed citations

15.

Martel‐Laferrière, Valérie, Kian Bichoupan, Emily Schonfeld, et al.. (2013). Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir‐based triple therapy. Liver International. 34(7). 1018–1024. 2 indexed citations

16.

Martel‐Laferrière, Valérie, Kian Bichoupan, Emily Schonfeld, et al.. (2012). 1137 EFFECTIVENESS OF HCV TRIPLE THERAPY WITH TELAPREVIR IN NEW YORK CITY. Journal of Hepatology. 56. S449–S449. 3 indexed citations

17.

Politi, Katerina, Maureen F. Zakowski, Pang‐Dian Fan, et al.. (2006). Lung adenocarcinomas induced in mice by mutant EGF receptors foundin human lung cancers respondto a tyrosine kinase inhibitor orto down-regulation of the receptors. Genes & Development. 20(11). 1496–1510. 353 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact